Your browser doesn't support javascript.
loading
Prostate cancer: the best fit for enzalutamide in metastatic prostate cancer.
Pal, Sumanta K; Sartor, Oliver.
Affiliation
  • Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
  • Sartor O; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Nat Rev Clin Oncol ; 11(9): 504-6, 2014 Sep.
Article in En | MEDLINE | ID: mdl-25073005
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prostatic Neoplasms, Castration-Resistant / Androstenols / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prostatic Neoplasms, Castration-Resistant / Androstenols / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Estados Unidos